Aldeyra Therapeutics, Inc. (ALDX) stock
ALDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.69+0.02 (+3.63%)
Close on Nov 17, 2026Market cap $41.86MP/E –Yield –
Aldeyra Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Aldeyra Therapeutics's pe ratio was 10.3× on Jan 30, 2015.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2015 | Jan 30, 2015 | 10.3× | +4.1 |
| 2014 | Dec 31, 2014 | 6.1× | – |
See a number that looks wrong?